CSIMarket
 


Charles River Laboratories International inc   (CRL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cumulative Charles River Laboratories International Inc 's Leverage Ratio for Trailing Twelve Months Period

CRL's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

CRL Leverage Ratio for Trailing Twelve Months Period

(Dec 30 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jul 01 2023)
II. Quarter
(Apr 01 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth 20.84 % 25.75 % 22.79 % 19.08 % 17.41 %
Y / Y Total Liabilities Growth -0.15 % -10.07 % -8.13 % 2.16 % 2.15 %
Leverage Ratio for Trailing Twelve Months Period 1.28 1.34 1.45 1.57 1.63
Total Ranking # 1371 # 2206 # 2414 # 2628 # 3086
Seq. Equity Growth 8.81 % 1.63 % 4.61 % 4.45 % 13.23 %
Seq. Total Liabilities Growth 7.54 % -4.97 % -1.52 % -0.78 % -3.14 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 30 2023
On the trailing twelve months basis Despite net new borrowings of 7.54% Charles River Laboratories International Inc managed to decrease Leverage Ratio for Trailing Twelve Months Period in IV. Quarter to 1.28, below Charles River Laboratories International Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Laboratories industry 18 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Charles River Laboratories International Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are CRL's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 19
Sector # 300
S&P 500 # 1252


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.18 1.81 1.35
(Apr 01 2017)   (Dec 30 2023)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 30 2023, within Medical Laboratories Industry Leverage Ratio for Trailing Twelve Months Period
Radnet Inc   3.51 
Iqvia Holdings Inc   3.09 
Opgen inc   2.19 
Inotiv Inc   2.08 
Malachite Innovations Inc   1.69 
Aclarion Inc   1.42 
Syneos Health Inc   1.35 
Charles River Laboratories International inc   1.31 
Fortrea Holdings Inc   1.24 
Medpace Holdings Inc   1.20 
Exagen Inc   1.17 
Exact Sciences Corporation  1.05 
Laboratory Corporation Of America Holdings  1.04 
National Research Corporation  0.93 
Natera inc   0.91 
Quest Diagnostics Inc  0.90 
American Shared Hospital Services  0.89 
Icon Plc  0.88 
Genetron Holdings Ltd  0.78 
Koninklijke Philips Nv  0.77 
Enzo Biochem Inc  0.76 
Hologic Inc  0.73 
Psychemedics Corp  0.68 
Dermtech Inc   0.65 
Luna Innovations Inc  0.64 
Vyant Bio Inc   0.53 
Personalis Inc   0.41 
Caredx Inc   0.35 
Celcuity Inc   0.33 
Burning Rock Biotech Limited  0.33 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com